1 min left

0% read

Abax Health

Technology Company

New York, New York, USA

Founded 2022

Each week, physicians see hundreds of thousands of patients and refer a percentage of them to specialists for additional testing and procedures.

Abax Health Overview

Each week, physicians see hundreds of thousands of patients and refer a percentage of them to specialists for additional testing and procedures. Thirty percent of those referrals never get scheduled, or patients go to a competing health system to get care, creating billions of dollars of untapped revenue annually.

Abax Health is the premier AI-driven, technology-enabled patient access platform and services firm, revolutionizing the way healthcare providers streamline patient access departments and maximize referral-based revenue.

Our industry-defining AI-powered technology empowers providers across the U.S. to increase revenue, reduce administrative burdens, and improve the patient experience, ensuring seamless, data-driven access to care.

With an obsessive focus on improving revenue, automation, and actionable intelligence, Abax Health is redefining the future of healthcare patient access, enabling organizations to maximize revenue and deliver superior patient care.

AI + Patient Access Workflow Software + Unscheduled Referrals = Increased Revenue and Patient Care

Let us help you realize your untapped revenue and generate new revenue streams for your organization.

Join the movement at abaxhealth.com.

Frequently Asked Questions About Abax Health

Abax Health is a software company. Each week, physicians see hundreds of thousands of patients and refer a percentage of them to specialists for additional testing and procedures.

Each week, physicians see hundreds of thousands of patients and refer a percentage of them to specialists for additional testing and procedures. 30% of those referrals never get scheduled or patients go to a competing health system to get care, creating billions of dollars of untapped revenue annual.

Abax Health has been operating since 2022. You can verify their legitimacy through their official website and social media presence.

Abax Health operates in the software sector of the cryptocurrency industry. Compare Abax Health with other software companies on Crypto News Navigator to evaluate services, features, and reputation before making your decision.

Before using Abax Health, research their track record (operating since 2022), verify their regulatory compliance, read user reviews, and understand their fee structure. Never share your private keys with any service, and start with small amounts until you are comfortable with the platform.

Safety depends on multiple factors including regulatory compliance, security practices, and track record. Abax Health is based in New York, New York, USA, has been operating since 2022. Always enable two-factor authentication, use strong passwords, and never store large amounts on any third-party platform.

Abax Health is based in New York, New York, USA, North America.

Abax Health was founded in 2022. The company currently has 56 employees.

Abax Health Details

Abax Health Tags

More About Abax Health

Work Model Details

Employees work from physical offices.

Latest from Academy

Bitcoin

VENOM

TEL

RSR

Why Venom Holders Stayed When The Price Crashed

Venom (VENOM) is a Layer 1 sovereign-grade blockchain whose 2024 airdrop deliberately weighted token allocation toward testnet developers and contributors rather than wallet-volume farmers. Six months after distribution, the network logs 90,000 daily active users and 150,000-200,000 daily transactions while VENOM trades at $0.019, down 97.5% from its all-time high of $0.7824. OKX delisted VENOM in June 2025 and Bybit followed on April 7, 2026. Despite that liquidity loss, on-chain data shows base-tier recipients sold quickly while testnet contributors held; circulating supply sits at 988.9 million of 8 billion max. CEO Christopher Louis Tsu's team announced a post-quantum migration plan to ML-DSA and ML-KEM in April 2026, alongside x402 protocol integration for AI-agent payments. The thesis: builder-weighted airdrops produce stickier holder bases that survive price collapse, but only if the underlying tech finds product-market fit before patience runs out.

Archie DuttonApr 29, 2026

8m read

Tech Deep Dives

XRD

VET

ROG

XRD Wallet Security Went From Afterthought to Industry Standard

Radix (XRD) is a Layer 1 smart contract platform whose Babylon mainnet, live since September 28, 2023, makes blind signing structurally impossible at the wallet level. Network TVL climbed from $21.5M to $49.3M in fourteen days during March 2026, ranking the chain 51st on DefiLlama. The Babylon upgrade replaced encoded function calls with human-readable transaction manifests, a pattern now drawing attention in Cosmos and NEAR developer forums. Atlan Digital conducted a pre-launch security assessment; the chain has reported zero major exploits since launch. XRD trades at $0.001288 with a $17.28M market cap (#766 on CoinMarketCap). Founder Dan Hughes passed away unexpectedly in July 2025, with CEO Andy Jarrett now leading the Radix Foundation alongside Chief Strategy Officer Adam Simmons and Finance Director Jonathan Day. The thesis: Radix's transaction manifest design is becoming the reference pattern for minimum DeFi wallet security, even as XRD's market cap remains a footnote.

Mia HallandApr 29, 2026

9m read

Crypto Basics

HSK

ENA

NPC

HashKey Platform Token Makes Sense for One Type of Trader

HashKey Platform Token works like a loyalty card, not a lottery ticket. Trading at $0.17 and 93.8% below its all-time high of $2.56, HSK isn't a speculative moonshot. It's a utility token that makes economic sense in only one use case: traders already staked into HashKey's Exchange ecosystem who want reduced fees, staking access, and a regulated onramp into Hong Kong's crypto market.

Katerina KulikovskaApr 28, 2026

7m read